Article
Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment.
Addiction biology - 1 Jan 2024
Dunn Kelly E, Huhn Andrew S, Finan Patrick H, Mange Ami, Bergeria Cecilia L, Maher Brion S, Rabinowitz Jill A, Strain Eric C, Antoine Denis
Abstract excerpt
Allelic variations in the A118G SNP of the OPRM1 gene change opioid signaling; however, evaluations of how allelic differences may influence opioid effects are lacking. This human laboratory paradigm examined whether the AA versus AG/GG genotypes determined opioid response profiles. Individuals with limited opioid exposure (N = 100) completed a five-day within-subject, double-blind, placebo-controlled,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
